home / stock / xers / xers short
Short Information | Xeris Pharmaceuticals Inc. (NASDAQ:XERS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 5,369,987 |
Total Actual Volume | 24,926,017 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 268,499 |
Average Short Percentage | 22.20% |
Is there a XERS Short Squeeze or Breakout about to happen?
See the XERS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $2.16 | $2.06 | $2.165 | $2.03 | 1,374,071 | 364,968 | 26.56% |
07-01-2024 | $2.24 | $2.17 | $2.28 | $2.16 | 839,954 | 184,599 | 21.98% |
06-28-2024 | $2.28 | $2.25 | $2.3199 | $2.2 | 2,849,271 | 208,332 | 7.31% |
06-27-2024 | $2.2 | $2.26 | $2.27 | $2.18 | 932,658 | 264,514 | 28.36% |
06-26-2024 | $2.09 | $2.2 | $2.22 | $2.07 | 1,383,829 | 368,316 | 26.62% |
06-25-2024 | $2.11 | $2.1 | $2.165 | $2.09 | 621,156 | 136,753 | 22.02% |
06-24-2024 | $2.12 | $2.11 | $2.18 | $2.095 | 750,243 | 148,865 | 19.84% |
06-21-2024 | $2.12 | $2.11 | $2.16 | $2.084 | 1,559,881 | 158,580 | 10.17% |
06-20-2024 | $2.1 | $2.09 | $2.16 | $2.09 | 998,035 | 246,244 | 24.67% |
06-18-2024 | $2.18 | $2.13 | $2.1914 | $2.1 | 871,609 | 187,231 | 21.48% |
06-17-2024 | $2.17 | $2.18 | $2.21 | $2.15 | 838,658 | 198,420 | 23.66% |
06-14-2024 | $2.19 | $2.2 | $2.25 | $2.17 | 778,300 | 139,944 | 17.98% |
06-13-2024 | $2.24 | $2.22 | $2.27 | $2.19 | 908,432 | 182,079 | 20.04% |
06-12-2024 | $2.33 | $2.24 | $2.38 | $2.22 | 1,348,488 | 228,039 | 16.91% |
06-11-2024 | $2.31 | $2.3 | $2.32 | $2.23 | 1,354,554 | 283,856 | 20.96% |
06-10-2024 | $2.33 | $2.32 | $2.395 | $2.285 | 1,149,307 | 252,915 | 22.01% |
06-07-2024 | $2.35 | $2.33 | $2.5 | $2.31 | 1,811,302 | 575,384 | 31.77% |
06-06-2024 | $2.41 | $2.36 | $2.44 | $2.335 | 959,299 | 259,258 | 27.03% |
06-05-2024 | $2.37 | $2.43 | $2.44 | $2.32 | 1,747,746 | 486,923 | 27.86% |
06-04-2024 | $2.43 | $2.32 | $2.45 | $2.2406 | 1,849,224 | 494,767 | 26.76% |
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
In patients with Cushing’s syndrome maintained on Recorlev, a lower baseline mUFC was associated with higher cortisol normalization rate. Lower mUFC at baseline was also associated with lower maintenance dose requirements and lower rates of potentially clinically important liver-re...
XeriSol™ formulation enabled predictable bioavailability and sustained levels of levothyroxine in a once-weekly subcutaneous presentation Once-weekly SC levothyroxine (XP-8121) participants normalized TSH/T4 levels using 45% less drug than would be needed for their daily oral dose ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a f...